Two repair blends from the same family. KLOW is GLOW plus one compound.
KLOW is GLOW with KPV added. GLOW is GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg in a 70 mg vial. KLOW is the same three plus KPV 10 mg, in an 80 mg vial. Everything else about them is the same.
| GLOW Blend | KLOW Blend | |
|---|---|---|
| What it is | GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg | KPV 10 mg + GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg |
| Evidence tier | Preclinical | Preclinical |
| Route | Subcutaneous | Subcutaneous |
| Half-life | Mixed (component-dependent) | Mixed (component-dependent) |
| Vial sizes | 70 mg | 80 mg |
| Water we suggest | 3 mL | 3 mL |
| Reported doses | 1.4 mg, 2.8 mg, 4.2 mg | 1.6 mg, 3.2 mg, 4.8 mg |
| Has a schedule | no | no |
KPV is the C-terminal tripeptide of alpha-MSH, studied for anti-inflammatory activity particularly in gut and skin models. It is the reason to pick KLOW over GLOW rather than any change to the other three components.
Neither blend splits evenly. GHK-Cu is the bulk of both vials at 50 mg, so a dose that gives you 1 mg of GHK-Cu gives far less of the others. Every dose figure on both pages is stated per component for that reason.